)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Chatham Rock Phosphate
Chatham Rock Phosphate (CRP) investor relations material
Chatham Rock Phosphate H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary3 Mar, 2026
Executive summary
Report covers unaudited consolidated results for the three and nine months ended December 31, 2025 and 2024, expressed in Canadian dollars.
The group operates in New Zealand, French Polynesia, and Australia, focusing on phosphate mining projects.
Net loss for the nine months ended December 31, 2025 was $725,733, an improvement from $1,006,426 loss in the prior year.
The company remains in a development stage and expects to incur further losses as it advances its projects.
Financial highlights
Total assets at December 31, 2025 were $6,808,863, down from $6,876,175 at March 31, 2025.
Cash and cash equivalents increased to $71,441 from $35,206 at March 31, 2025.
Revenue remains minimal; expenses for the nine months were $754,372, down from $1,007,508 year-over-year.
Basic and diluted loss per share for the nine months was $(0.007), improved from $(0.010) year-over-year.
Shareholders' equity decreased to $6,283,488 from $6,476,041 at March 31, 2025.
Outlook and guidance
Management expects continued losses as development progresses and is actively seeking additional capital.
The group is considering farm-downs or asset sales to advance commercialization, particularly for the Chatham Rise project.
A non-binding term sheet was signed with an interested party for a potential earn-in of up to 75% in Chatham Rise, pending due diligence.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Chatham Rock Phosphate
- Material uncertainty over going concern persists as losses continue and key permits remain outstanding.CRP
H2 2025 - Net loss narrowed to $1.47M, but future depends on capital raises and permit success.CRPH2 2024
- Net loss narrowed as capital raises continued, but funding and permitting risks remain.CRPH1 2025
Next Chatham Rock Phosphate earnings date
H2 202620 Nov, 2026
Chatham Rock Phosphate
Next Chatham Rock Phosphate earnings date
H2 202620 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Chatham Rock Phosphate Limited is a New Zealand-based mineral exploration company focused on the development of phosphate resources. The company's primary project involves extracting phosphate nodules from the seabed off the coast of New Zealand. These phosphate deposits are intended for use as a natural, low-cadmium fertilizer to support sustainable agriculture. Chatham Rock Phosphate seeks to provide an alternative source of phosphate for the agricultural industry, aiming to reduce reliance on imported fertilizers and promote environmentally friendly farming practices. The company is headquartered in Wellington, New Zealand, and its shares are listed on the NZX.